NLRP3 and COVID-19: Additionally, using a cohort of COVD-19 patients with different disease severity status, the main inflammatory cytokine of the NLRP3 inflammasome pathway, IL-1β, was shown to be significantly upregulated in severe COVID-19 patients when compared to asymptomatic patients.